Recherche sur therapies

Documentation pour "therapies"

Il y a 111 document(s) pour l'expression "therapies" sur spider-pdf.com

• 17 2 2003 libdoc.who.int - 12/06/2011 03:24:53 ...for nausea and vomiting during chemotherapy Agalsidase beta approved Imatinib mesylate approved for paediatric leukaemia Drug-eluting stent for clogged heart arteries Pegvisomant for acromegaly 104 105 105 105 105 106 106 107 107 108 108 109 Personal Perspectives Pharmacogenetics and existing therapies 84 Safety Issues Fluticasone and adrenal crisis Thiazolidinediones experience Cefepime, ceftazidime and neurotoxicity Interstitial nephritis and proton pump inhibitors Interactions with grapefruit juice 92 92 93 94 95 Current Topics New network for guideline development Fake artesunate tablets... Infos PDF : 30/07/2003 - 36 p. - 0.55 Mo - Version HTML

http://libdoc.who.int/druginfo/17_2_2003.pdf

• lietaer97-99books39-00 www.vvcepc.be - 20/03/2012 22:25:00 ...century. London: Constable. Brazier, D. (Ed.). (1997). Más allá de Carl Rogers. Bilbao: Desclée De Brouwer. [Trans.] Buchanan, L., & Hughes, R. (2000). Experiences of Person-Centred Counselling Training. Llangarron, Ross-on-Wye: PCCS Books. Cain, D., & Seeman, J. (2001). Humanistic psychotherapies: Handbook of research and practice. Washington: A.P.A. Campbell, P. A., & McMahon, E. M. (1992). Biospiritualiät. Glaube beginnt im Körper. Ein praktische Einführung zur Selbsterfahrung mit Focusing. München: Claudius. [Trans.] Campbell, P., & McMahon, E. (1997). Biospirituality: Focusing as a way... Infos PDF : 13/01/2003 - 116 p. - 0.62 Mo - Version HTML

http://www.vvcepc.be/images/bestanden/lietaer97-99books39-00.pdf

• EPPOSI 11th PRDTD Presentations www.epposi.org - 03/02/2011 03:42:23 ...terminology u Natural history u Ontology of rare diseases + cross-referencing to animal diseases ontology l Translational/preclinical research u Predictive, validated in vitro models and in vivo animal models l Clinical research u Validated biomarkers and surrogate end-points u New diagnostics and therapies u Repurposing of drugs 12 Information EU research: http://ec.europa.eu/research Seventh Framework Programme: http://ec.europa.eu/research/fp7 Information on research programmes and projects: http://cordis.europa.eu/ http://ec.europa.eu/research/research-eu/ Information requests: http://ec.europa... Infos PDF : 385 p. - 33.49 Mo - Version HTML

http://www.epposi.org/upl/1/default/doc/EPPOSI 11th PRDTD_Presentations.pdf

• 11th PRDTD PGM final www.epposi.org - 03/02/2011 03:42:07 ... Information Centre for Rare Diseases and Orphan Drugs, Bulgaria Discussion with the Audience 17.45 20.00 END of DAY 1 Dinner (Diplomat Hotel) 5 TUESDAY 30 NOVEMBER 08.00 Doors Open SESSION 2 DEVELOPING REGULATION : THE EU AND BEYOND: FUTURE REGULATIONS AND POLICIES FOR BETTER RARE DISEASE THERAPIES Sessions Moderators: Lesley Greene, CLIMB United Kingdom Kerstin Westermark, Chair, EMA COMP United Kingdom 08.30 Introduction Lesley Greene, CLIMB - United Kingdom 08.40 The EU added-value: Sharing best measures for the development of rare diseases therapies Wills Hughes-Wilson, Genzyme Belgium... Infos PDF : 25/11/2010 - 22 p. - 1.16 Mo - Version HTML

http://www.epposi.org/upl/1/default/doc/11th PRDTD_PGM_final.pdf

• EPPOSI-10th PRDTD-Report low www.epposi.org - 23/04/2011 03:34:34 ...decade, to identify progress and to re-examine areas where more might need to be done. And the timing could not be better. The next 5 years will provide unrivalled opportunities to address outstanding areas in the key areas of increasing productivity and attractiveness of research into rare disease therapies, how to improve the success rate of orphan drug development from research through to approved therapy and, finally, how to ensure that there are sustainable systems to give patients access to the fruits of this research and development. With the Commission Communication and the Council... Infos PDF : 11/02/2010 - 32 p. - 0.4 Mo - Version HTML

http://www.epposi.org/upl/1/default/doc/EPPOSI-10th PRDTD-Report_low.pdf

• lietaer91-93 www.vvcepc.be - 20/03/2012 22:24:40 ...Engle, D., & MacDonald, R. (1991). Looking for differential psychotherapy efficacy. Journal of Psychotherapy Integration, 1, 121-142. Beutler, L. E., Machado, P. P. P., Engle, D., & Mohr, D. (1993). Differential patient and treatment maintenance among cognitive, experiential and self-directed psychotherapies. Journal of Psychotherapy Integration, 3, 15-31. Bihm, E. M., & Leonard, P. J. (1992). Counseling persons with mental retardation and psychiatric disorders: A preliminary study of mental health counselors perceptions. Journal of Mental Health Counseling, 14, 225-233. Bixler, R. H. (1990). Carl... Infos PDF : 13/01/2003 - 112 p. - 0.49 Mo - Version HTML

http://www.vvcepc.be/images/bestanden/lietaer91-93.pdf

• 434 Complementary Therapies www.dementie.be - 19/11/2011 02:36:16 ...SOCIETY INFORMATION SHEET · JANUARY 2001 information sheet 434 Complementary therapies and dementia This sheet provides information on a range of complementary therapies. While these approaches will not cure dementia, they may help relieve some of the symptoms and generally help improve the quality of life for the person with dementia and their carers. What are complementary therapies? Complementary therapies aim to heal the whole person, addressing not only... Infos PDF : 24/01/2001 - 2 p. - 0.02 Mo - Version HTML

http://www.dementie.be/SiteFiles/434_Complementary_Therapies.pdf

• Consensus2009 www.oncoconferences.ch - 21/07/2011 02:35:54 ...of Oncology Advance Access published June 17, 2009 special article Annals of Oncology doi:10.1093/annonc/mdp322 Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 A. Goldhirsch1,2*, J. N. Ingle3, R. D. Gelber4, A. S. Coates5, B. Thurlimann6, H.-J. Senn7 ¨  & Panel members International Breast Cancer Study Group, Oncology Institute of Southern... Infos PDF : 16/06/2009 - 11 p. - 0.11 Mo - Version HTML

• EPPOSI 11th PRDTD conference paper www.epposi.org - 23/04/2011 03:34:44 ...and learnings from the sector can be extrapolated to much broader healthcare policies. Rare diseases can, in fact, serve as an experimental societal laboratory for new healthcare and social systems covering a wide range of fields, including the fostering of basic research, research on advanced therapies, improvement in best practices for clinical research, implementation of mechanisms for facilitating access to affordable drugs, the establishment of relevant expert networks and the development of specialised rehabilitation services for patients, to name just a few. These diseases have in common... Infos PDF : 13/10/2010 - 4 p. - 0.26 Mo - Version HTML

http://www.epposi.org/upl/1/default/doc/EPPOSI_ 11th PRDTD _conference paper.pdf

• lietaer94-96 www.vvcepc.be - 20/03/2012 22:24:50 ...of psychotherapy: Theory and practice. New York: Oxford University Press. Ballou, M. (1995). Focusing. In M. Ballou (Ed.), Psychological interventions: A guide to strategies (pp. 117-124). Westport: Praeger/Greenwood. Bankart, C. P. (1996). Talking cures. A history of Western and Eastern psychotherapies. Pacific Grove: Brooks/Cole. 16 K-m K-b D-m B B-f K-n D-a K-j K-j Barak, Y., & Rabinowitz, G. (1995). Gestalt elements in D. W. Winnicott's psychoanalytic technique. Gestalt Journal, 18(2), 87-91. Barba, S. (1994). Subtle mind subtle body. An interface approach: the use of experiential focusing... Infos PDF : 13/01/2003 - 90 p. - 0.4 Mo - Version HTML

http://www.vvcepc.be/images/bestanden/lietaer94-96.pdf